BioAffinity Technologies
San Antonio
About BioAffinity Technologies
BioAffinity Technologies applies experience, intelligence and creativity to the global fight against cancer, the company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. The company uses technology that preferentially targets cancer cells and cell types indicative of a sick condition to produce exclusive noninvasive diagnostic tests and cancer therapies. The business is engaged in the development of technologies that, in the future, will be able to diagnose, track, and treat a variety of cancers, including lung ailments. BioAffinity Technologies was established in 2014 in San Antonio, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $44.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:BIAF
- Website: bioaffinitytech.com
- Phone: (210)-698-5334
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bioaffinity-technologies-80416 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.